If there is one intermarket relationship that every stock market investor should be following, it's got to be the Discretionary vs Staples ratio.

Consumer Discretionary...

From the Desk of Louis Sykes @haumicharts

In yesterday's letter, we discussed in great detail the considerations when applying AVWAP analysis to cryptocurrencies.

You can...

We debuted a new scan recently- The Outperformers.

The Outperformers is our newest scan that...

Insiders are finally buying into the summer rally. We haven’t seen this much action on our Hot List in months!

The largest insider transaction on today’s list is a Form 4 filing by the Chairman and CEO of American Assets Trust $AAT, with a...

There she goes!

Apple just went out at new all-time highs relative to the S&P500.

I think about it like this: Should we...

From the Desk of Steve Strazza @Sstrazza

We held our August Monthly Strategy Session Monday night. Premium Members can access and re-watch it here.

Non-...

From the desk of Willie Delwiche.

We are still waiting for evidence that the bear market in equities has run its course, and a new bull market is being reborn. We have seen the short-term risk...

If tech stocks are signaling that a bottom is in, we're of the mind that we'll find some significant beta in a badly beaten household name: The recently renamed Meta $META (otherwise known as Facebook...).

Chatting with JC this morning, he was...

From the Desk of Louis Sykes @haumicharts

In the arsenal of every trader and technical analyst lies a countless number of indicators, metrics, and tools.

Everyone in the business is aware of the classic indicators: moving...

When the worst stocks on the planet can't go down any more, that's usually good information.

We saw a lot of Small-cap Growth, Arkk Funds, Biotech, Chinese Internet and...

B. Riley Financial $RILY Director Randall Paulson reported another purchase of stock in the asset manager. His last purchase was in early May.

New Bull Market or just a Bear Market Rally?

That's the question I keep seeing.

And it's a fair one to ask.

From the desk of Willie Delwiche.

The largest insider transaction on today's list is a Form 4 filing by Artal Group, which reported a purchase of roughly $40.4 million in Lexicon Pharmaceuticals $LXRX.

Artal Group now owns 83,835,950 LXRX shares, representing a roughly 47.5%...